Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy a longitudinal study

Obstetrics and Gynecology

Volumn 89, Issue 5, 1997, Pages 743-746

  Gilson, George J ^a,b   Graves, Steven W ^a,b   Qualls, Clifford R ^a,b   Curet, Luis B ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIGITALIS LIKE FACTOR;

ADULT; ARTICLE; BINDING SITE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART PERFORMANCE; HUMAN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADENOSINE TRIPHOSPHATASES; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL AVAILABILITY; CARDENOLIDES; DIGOXIN; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; SAPONINS;

EID: 0030933553     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00090-2     Document Type: Article

References (13)

1. Graves SW, Valdez R Jr, Brown BA, Knight AB, Craig HR. Endogenous digoxin-like substance in human pregnancies. J Clin Endocrinol Metab 1984;58:748-51.
2. Elias AN, Vaziri ND, Pandian MR, Powers DR, Domurat E. Atrial natriuretic peptide and arginine vasopressin in pregnancy and pregnancy-induced hypertension. Nephron 1988;49:140-3.
3. Hatjis CG, Kofinas AD, Greelick JP, Swain M, Rose JC. Interrelationship between atrial natriuretic factor concentrations and acute volume expansion in pregnant and nonpregnant women. Am J Obstet Gynecol 1990;163:45-50.
4. Tao QF, Soszynski PA, Hollenberg NK, Graves SW. Sensitive assay for sodium pump inhibition. Clin Chem 1994:40:1595-6.
5. Valdez R. Endogenous digoxin-immunoreactive factor in human subjects. Fed Proc 1985;44:2800-5.
6. Phelps SJ, Cochran EB, Gonzalez AR, Tolley EA, Hammon KD, Sibai BM. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substances. Am J Obstet Gynecol 1988;158: 34-9.
7. Kerkez SA, Poston L, Wolfe CD, Quartero HW, Carabelli P, Petruckevitch A, et al. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy-induced hypertension. Am J Obstet Gynecol 1990;162: 783-7.
8. Goodlin RC, Makowski EL. Fetal endoxins and complications of pregnancy. West J Med 1988;148:590-2.
9. Kaminski K, Rechberger T. Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy induced hypertension. Am J Obstet Gynecol 1991;165:733-6.
10. Haber E, Haupert GT. The search for a hypothalamic Na+K+-ATPase inhibitor. Hypertension 1987;9:315-24.
11. Hollenberg NK, Graves SW. Koch’s postulates and the digitalislike factor. Hypertens Res 1995;18:1-6.
12. Valdes R, Graves SW. Protein binding of endogenous digoxin-immunoreactive factors in human serum and its variation with clinical condition. J Clin Endocrinol Metab 1985;60:1135-43.
13. Gilson GJ, Samaan S, Crawford MH, Curet LB, Foster A. Changes in hemodynamics, ventricular remodeling, and left ventricular function in normal pregnancy: A longitudinal study. Obstet Gynecol 1997 (in press).